TriSalus Life Sciences, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -3.7% | -3.7% | 1.9% |
| FY2022 | 26.6% | 26.6% | -214.5% |
| FY2023 | 219.3% | 219.3% | -241.3% |
| FY2024 | 116.0% | 788.6% | -125.3% |
| FY2025 | 115.8% | 4,813.1% | -111.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -3.7% | -3.7% | 1.9% |
| FY2022 | 26.6% | 26.6% | -214.5% |
| FY2023 | 219.3% | 219.3% | -241.3% |
| FY2024 | 116.0% | 788.6% | -125.3% |
| FY2025 | 115.8% | 4,813.1% | -111.0% |